Business Segments Abbott Laboratories Swiss Exchange
Stocks
ABT
US0028241000
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 77.50 CHF | +1.97% |
|
+3.33% | -21.72% |
| 06/07 | Evercore ISI Adjusts Abbott Laboratories Price Target to $112 From $120 | MT |
| 03/07 | Missouri jury sides with Enfamil maker Mead Johnson in case over preterm baby formula | RE |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Therapeutic Devices | ||||||||||
Medical Devices | 1.44TCr | 1.47TCr | 1.69TCr | 1.9TCr | 2.14TCr | |||||
Total Assets | 726.1Cr | 784.4Cr | 902.9Cr | 947.2Cr | 1.07TCr | |||||
CAPEX | -35Cr | -34Cr | -60Cr | -63Cr | -66Cr | |||||
D&A | 28Cr | 31Cr | 32Cr | 34Cr | 38Cr | |||||
Operating Income | 451.4Cr | 440.9Cr | 530.6Cr | 615.3Cr | 721.2Cr | |||||
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
Diagnostics | 1.56TCr | 1.66TCr | 998.8Cr | 934.1Cr | 893.7Cr | |||||
Total Assets | 769.9Cr | 798.5Cr | 776.7Cr | 767.8Cr | 827.3Cr | |||||
CAPEX | -98Cr | -83Cr | -75Cr | -76Cr | -76Cr | |||||
D&A | 76Cr | 49Cr | 50Cr | 52Cr | 53Cr | |||||
Operating Income | 625.6Cr | 666.7Cr | 243.3Cr | 207.3Cr | 174Cr | |||||
Vitamins and Nutritional Supplements | ||||||||||
Nutrition | 829.4Cr | 745.9Cr | 815.4Cr | 841.3Cr | 845.1Cr | |||||
Total Assets | 342.5Cr | 362.5Cr | 427Cr | 440.4Cr | 479.1Cr | |||||
CAPEX | -17Cr | -25Cr | -46Cr | -38Cr | -30Cr | |||||
D&A | 15Cr | 16Cr | 16Cr | 16Cr | 18Cr | |||||
Operating Income | 176.3Cr | 71Cr | 133.3Cr | 150.5Cr | 155.8Cr | |||||
Pharmaceutical Products | ||||||||||
Established Pharmaceutical | 471.8Cr | 491.2Cr | 506.6Cr | 519.4Cr | 553.6Cr | |||||
Total Assets | 278.9Cr | 288.3Cr | 311.8Cr | 308.7Cr | 354Cr | |||||
CAPEX | -17Cr | -18Cr | -18Cr | -18Cr | -17Cr | |||||
D&A | 9.4Cr | 9.7Cr | 10Cr | 9.6Cr | 10Cr | |||||
Operating Income | 89Cr | 104.9Cr | 120.6Cr | 123.3Cr | 129Cr | |||||
Optical Healthcare | ||||||||||
Other | 5.2Cr | 1.1Cr | 1.4Cr | 1.6Cr | 1.7Cr | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | -20Cr | -18Cr | -21Cr | -29Cr | -26Cr | |||||
D&A | 20Cr | 20Cr | 20Cr | 22Cr | 25Cr | |||||
Operating Income | - | - | - | - | - | |||||
Operating Income | -80Cr | -51Cr | -31Cr | -42Cr | -16Cr | |||||
Operating Income | -204.7Cr | -201.3Cr | -196.6Cr | -187.8Cr | -168.2Cr | |||||
Operating Income | -64Cr | -68Cr | -64Cr | -67Cr | -66Cr | |||||
Total Assets | 3.6TCr | 3.33TCr | 3.25TCr | 2.98TCr | 2.96TCr | |||||
Total Assets | 698.7Cr | 791.2Cr | 845.8Cr | 1.82TCr | 2TCr | |||||
Total Assets | 1.11TCr | 1.09TCr | 807.8Cr | 885.3Cr | 985.7Cr |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 1.66TCr | 1.81TCr | 1.55TCr | 1.63TCr | 1.71TCr | |||||
Total Assets | 680Cr | 770Cr | 890Cr | 1.03TCr | 1.19TCr | |||||
All Other Countries | 1.55TCr | 1.48TCr | 1.41TCr | 1.48TCr | 1.6TCr | |||||
Germany | 257.2Cr | 234Cr | 234.5Cr | 253.9Cr | 275.9Cr | |||||
China | 239.2Cr | 213.3Cr | 225.3Cr | 211.3Cr | 190.7Cr | |||||
Switzerland | 131.3Cr | 133.6Cr | 163.8Cr | 174.7Cr | 187.1Cr | |||||
India | 156.1Cr | 164.9Cr | 175Cr | 181.7Cr | 187.1Cr | |||||
Japan | 169.5Cr | 193.2Cr | 151.3Cr | 144.1Cr | 147.5Cr | |||||
United Kingdom | - | - | - | - | 134Cr | |||||
Vietnam | - | - | - | - | - | |||||
Colombia | - | - | - | - | - | |||||
Russia | - | - | - | - | - | |||||
Brazil | - | - | - | - | - | |||||
France | - | - | - | - | - | |||||
Italy | - | - | - | - | - | |||||
Total Assets | 630Cr | 650Cr | 730Cr | 820Cr | 1.03TCr | |||||
The Netherlands | - | - | 107.4Cr | 112.4Cr | - | |||||
Canada | 138.5Cr | 128Cr | - | - | - |
- Stock Market
- Stocks
- ABT Stock
- ABT Stock
- Financials Abbott Laboratories
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
















